Evidence map›Paper›PMID 39927364›Full record

ArticleOpen veterinary journal2024

Robust anticancer efficacy of

Nabil A Soliman, Amr A Shalaby, Heba Allah Mohamed, Sara M Abdelkarem Alashqar, Mohamed Ahmed Ammar

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Open veterinary journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nabil A SolimanZoology Department, Faculty of Science, Zagazig University, Sharkia, Egypt.
Amr A ShalabyZoology Department, Faculty of Science, Zagazig University, Sharkia, Egypt.
Heba Allah MohamedZoology Department, Faculty of Science, Zagazig University, Sharkia, Egypt.
Sara M Abdelkarem AlashqarZoology Department, Faculty of Science, Zagazig University, Sharkia, Egypt.
Mohamed Ahmed AmmarZoology Department, Faculty of Science, Zagazig University, Sharkia, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Breast cancer, a prevalent disease affecting women globally, is particularly aggressive and has limited treatment options. Aim: Snake venom, containing active chemicals, has shown potential in medicine. Methods: The study investigates the anticancer effect of Egyptian cobra Results: The study involved administering Conclusion: The study found that venom treatment in groups G4 and G5 significantly improved inflammatory cytokine and tumor markers levels, increased expression of tumor-suppressor genes, and increased apoptosis and necrosis.

Indexed as

Antineoplastic AgentsElapid VenomsNanoparticlesTriple Negative Breast NeoplasmsAnimalsFemaleHumansNaja najaRatsSilicon DioxideAntineoplastic AgentsElapid VenomsSilicon DioxideAnticancerInflammatory cytokinesNaja haje venomNPsTriple negative breast cancer

Identifiers

PMID39927364
PMCPMC11799658

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.